As scientists, we are constantly in search of faster, more efficient solutions for simplified and streamlined neuroscience research.
The perfect solution might not always be readily apparent but it’s always out there. Our team recognizes the importance of determination and drive.
We don’t shy away from our problems. When we’re faced with an obstacle, we look at the adversity head-on and keep working until we overcome it.
Scientific discovery is all about collaboration. Our goal is to partner with researchers to develop tools and technologies that are tailored to their work.
Our team is committed to our work, but never at the expense of our moral compass or a customer’s trust – integrity is central to everything we do.
We are a team of performers, each striving for excellence in their role delivering the best tools for cutting-edge research.
Leveraging decades of high-level experience in neuroscience research and probe design, our team focuses on developing solutions that streamline and simplify complex heart, brain, and nervous system research across the globe.
NeuroNexus is privately held by the NEL Group, Inc.
Dr. Daryl R. Kipke founded NeuroNexus in 2004. Since then, he has been instrumental in the company’s growth, overseeing its progression from university spin-out to the subsidiary of a large public med-tech company.
In 2019, he formed the NEL Group to re-acquire NeuroNexus and transition to an independent, growth-oriented model. Leveraging over 30 years of neurotechnology experience, Dr. Kipke focuses on advanced neural interface systems and analytics for neuromodulation, bioelectric medicine, and the life sciences. His research, which centers on developing advanced neural interface technologies that communicate with neural circuits in the brain, spinal cord, and autonomic nervous system, has resulted in over 200 scientific publications, numerous patents, and international recognition in neural engineering.
Before launching NeuroNexus, Dr. Kipke was Professor of Biomedical Engineering at the University of Michigan and Director of the Center for Neural Communication Technology
Since co-founding NeuroNexus in 2004, Dr. Rio Vetter has established himself as an accomplished executive and inspiring leader. Responsible for planning and directing all aspects of NeuroNexus’ technical infrastructure, Dr. Vetter’s strategic vision blends science, technology, and innovation with the commercial interests of the company.
With technical experience in biomedical engineering, neuroscience, electronic systems, and software signal processing algorithms that interface with the nervous/cardiac systems, Dr. Vetter understands the demands of the industry. He orchestrates the objectives of different groups to create a cohesive technology pipeline that starts with research and ends with the manufacturing of innovative, sellable products.
Dr. Vetter has a BSE and MSE in Biomedical Engineering from Arizona State University and a Ph.D. in Biomedical Engineering from the University of Michigan. His research has led to the creation of 30+ patents and numerous scientific publications.
One of NeuroNexus’s co-founders, Jamille Hetke brings extensive experience in neural probe design, MEMS processing, and advanced packaging to her current role as VP of Engineering. The lead engineer of neural interface projects and chief designer of neural probes, she is actively involved with product development, executive management, and the exploration of new business opportunities.
Ms. Hetke’s neural probe journey began at the University of Michigan, where she served on the Michigan Probe development team for over two decades. She received a B.S. in Electrical Engineering from Michigan State University and an M.S in Biomedical Engineering from the University of Michigan.
A fellow in the American Institute of Medical and Biological Engineering, Ms. Hetke is recognized as a leader in her field – her work has resulted in over 25 patents and numerous scientific publications.
As the Director of Operations at NeuroNexus, Priyanka Sehgal oversees the day-to-day operations of the company, ensuring that everything runs efficiently. Through this role, Ms. Sehgal was responsible for standardizing production and test processes – this has been instrumental in minimizing manufacturing variability. She is actively involved in the development and integration of new technologies.
Before her promotion to Director, Ms. Sehgal headed the quality and manufacturing department. Working in this capacity, she designed and implemented the company’s quality management system.
Ms. Sehgal has a BS in Biomedical Engineering from Maharshi Dayanand University in India and an MS in Biomedical Engineering from Wayne State University, Michigan.
Dr. Asiyeh Golabchi channels 10+ years of experience creating reliable, implantable neural interface devices into her work with NeuroNexus, leading customer interactions with the R&D team and matching product development with customer needs. She is also responsible for providing educational and technical support to maintain better customer relationships.
After obtaining her Ph.D. in Neuroscience and Brain Technologies, she served for 5 years as a postdoctoral fellow at the University of Pittsburgh.
Cathy brings a wealth of sales and sales leadership experience to every interaction. With a coaching-oriented approach, she has played a pivotal role in guiding hundreds of sales employees to success at renowned organizations. Over her extensive 30+ year career, Cathy has navigated various industries and her expertise extends to consistently building regional, national, specialty, inside, and growth sales teams.
Cathy’s passion lies in constructing and delving into CRM, sales metrics, compensation structures, and performance management to optimize the current situation. She possesses a keen ability to boost motivation, coach performance, and effectively manage successful sales teams. Her commitment to maintaining consistent expectations and implementing individualized performance improvement strategies are the hallmarks of her approach.
While obtaining his BS in Neuroscience at Indiana University, Nathan Berbesque developed a strong passion for research science, particularly in the fields of Huntington’s Disease, addiction, and cannabinoid physiology.
After graduating, he worked in academia, industry, and consulting before finding his calling as a Sales Manager with NeuroNexus. Nate enjoys sharing exciting new technologies and enabling top-notch neuroscience research.
Emery Clark brings natural curiosity, passion for the intersection of neuroscience and electrophysiology, and a successful track record to his role as a Sales Executive. Before joining NeuroNexus, he worked in consumer technology sales, product distribution, and industrial automation/engineering.
He graduated with a BS in Business Administration and a minor in economics from Oakland University.
As the Sales Operations Manager at NeuroNexus, Nicki Ziehr processes quotes into orders and acts as a liaison between the Sales Team and Production Team. In addition to ensuring that orders are accurate and delivered on time, she fosters and maintains relationships with customers.
Nicki received her Bachelor’s Degree in Business Administration from Siena Heights University.
While working as part of the sales team, Jeffrey Adams developed a wealth of knowledge about the NeuroNexus product line. Today, he uses these insights in his capacity as a Product Engineer. In addition to supporting sales and marketing initiatives, he heads the Quality Assurance team.
Jeffrey received a BS in Engineering from Michigan State University.
In her capacity as the Marketing and Media Specialist at NeuroNexus, Isabel Kurcz focuses on fostering connections with the neuroscience community via social media and other online channels. She enjoys collaborating with the team and contributing to the growth of an exciting field.
Isabel graduated with a BA from the University of Michigan.
Dr. Daryl R. Kipke is Chief Executive Officer and Managing Director of the NEL Group Inc. and NeuroNexus Inc. Dr. Kipke has led NeuroNexus through a remarkable business journey. With University of Michigan colleagues, he founded the company in 2004 as a university technology spinout and led it as Director and Chief Operating Officer through a successful exit in 2012 to Integer, Inc., a global leader in medical device manufacturing and design. He served as President of NeuroNexus as it operated as a subsidiary of Integer. In 2019, Dr. Kipke partnered with Thomas Hook and several neuro-tech leaders and founded the NEL Group, Inc. to acquire NeuroNexus from its corporate parent and operate it again as a high-growth commercial life science company centered on strong neurotechnology, neuroscience and analytics platforms.
Dr. Kipke is an accomplished engineer scientist and entrepreneur with over 30 years of experience working at the frontiers of neurotechnology. Dr. Kipke’s research centers on advanced, implantable neural interface systems to directly communicate — electrically, chemically, or optically — with precisely targeted regions in the brain, spinal cord, autonomic nervous system, and heart. Both Dr. Kipke’s former university research group and NeuroNexus are internationally recognized in neural interface technologies and neural engineering. He has advised numerous doctoral students and post-doctoral fellows, many of whom are now leaders across the academic, business and government sectors of neuroscience and neurotechnology. Dr. Kipke is a highly cited author and inventor with several hundred publications and patents.
Dr. Kipke received the B.S. in Engineering Science from the University of Michigan. He went on to receive M.S. (Bioengineering), M.S.E. (Electrical Engineering), and Ph.D. (Bioengineering) degrees, all from Michigan. After starting his academic scientific career at Arizona State University, he moved his research group to the University of Michigan to join the Biomedical Engineering faculty and establish the Neural Engineering Laboratory. While on the faculty at Michigan, Dr. Kipke served as Director of the Center for Neural Communication Technology, a NIH National Biotechnology Resource Center. In addition to NeuroNexus, he previously founded Neural Intervention Technologies, Inc., as a university spin-out and helped lead it through a successful exit to W.L Gore. He is a Fellow of the American Institute for Medical and Biological Engineering.
Thomas J. Hook is a Director of the NEL Group and NeuroNexus. Mr. Hook is currently the President and CEO of Barnes, a global leader in highly-engineered precision products, systems and solutions in healthcare, automation, mobility, packaging, and advanced manufacturing.
Mr. Hook previously served as CEO and Director of SaniSure, Inc., a global leader in the design and manufacturing of single-use systems and components for drug and vaccine manufacturing and other biotech applications. He also served as Chief Executive Officer of Q Holding Company and President and Chief Executive Officer and Chief Operating Officer of Integer (formerly Greatbatch), and previously held leadership positions at CTI Molecular Imaging and General Electric Medical Systems. His prior experience also includes service as Chairman of the Board and member of the Executive Committee of HealthNow New York, Inc., and as a Director of Tactiva Therapeutics, Inc. Mr. Hook started his career as a Nuclear Engineer in the U.S. Navy.
Mr. Hook holds an MBA from Vanderbilt University, a Master’s degree in Chemistry from the State University of New York at Buffalo, and a Bachelor of Science degree in Chemistry and Mathematics from St. Bonaventure University.
Interested in contributing to cutting-edge neuroscience research and neurotechnology product development? In addition to competitive wages, benefits, and a friendly team, NeuroNexus offers the opportunity to work on innovative, rewarding projects that move the industry forward.
If you have relevant experience and your views are aligned with our core values, we’d love to hear from you. Follow the link below to learn more.Explore Opportunities